Influence of processing-induced phase transformations on the dissolution of theophylline tablets

AAPS PharmSciTech

Volumn 5, Issue 1, 2004, Pages

  Debnath, Smita ^a,b   Suryanarayanan, Raj ^b  

^a MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Anhydrous theophylline; Crystallinity; Dissolution; Hardness; Tablet

Indexed keywords

THEOPHYLLINE; CELLULOSE; WATER;

ARTICLE; CRYSTALLIZATION; DRUG GRANULE; DRUG SOLUBILITY; DRUG TRANSFORMATION; PHYSICAL CHEMISTRY; POWDER; PREDICTION; TABLET DISINTEGRATION TIME; TABLET FORMULATION; WATER VAPOR; CHEMISTRY; KINETICS; METHODOLOGY; SOLUBILITY; TABLET;

CELLULOSE; CHEMISTRY, PHARMACEUTICAL; KINETICS; POWDERS; SOLUBILITY; TABLETS; THEOPHYLLINE; WATER;

EID: 23144438959     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt050108     Document Type: Article

References (30)

1. Shefter E, Higuchi T. Dissolution behavior of crystalline solvated and nonsolvated forms of some pharmaceuticals. J Pharm Sci. 1963;52:781-791.
2. Urakami K, Shono Y, Higashi A, Umemoto K, Godo M. A novel method for estimation of transition temperature for polymorphic pairs in pharmaceuticals using heat of solution and solutibility data. Chem Pharm Bull. 2002;50:263-267.
3. Hancock BC, Parks M. What is the true solubility advantage for amorphous pharmaceuticals? Pharm Res. 2000;17:397-404.
4. Elamin AA, Ahlneck C, Alderborn G, Nystrom C. Increased metastable solubility of milled griseofulvin, depending on the formation of a disordered surface structure. Int J Pharm. 1994;111:159-170.
5. Brittain HG, Morris KR, Bugay DE, Thakur AB, Serajuddin ATM. Solid-state NMR and IR for the analysis of pharmaceutical solids: polymorphs of fosinopril sodium. J Pharm Biomed Anal. 1993;11:1063-1069.
6. Otsuka M, Matsumoto T, Kaneniwa N. Effects of the mechanical energy of multi-tableting compression on the polymorphic transformations of chlorpropamide. J Pharm Pharmacol. 1989;41:665-669.
7. Phadnis NV, Suryanarayanan R. Polymorphism in anhydrous theophyl-line - implications on the dissolution rate of theophylline tablets. J Pharm Sci. 1997;86:1256-1263.
8. Alsaidan SM, Alsughayer AA, Eshra AG. Improved dissolution rate of indomethacin by adsorbents. Drug Dev Ind Pharm. 1998;24:389-394.
9. Osawa T, Kamat M, DeLuca P. Hygroscopicity of cefazolin sodium: Application to evaluate the crystallinity of freeze-dried products. Pharm Res. 1988;5:421-425.
10. Morris KR, Griesser UJ, Eckhardt CJ, Stowell JG. Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes. Adv Drug Del Rev. 2001;48:91-114.
11. Ono M, Tozuka Y, Oguchi T, Yamamoto K. Effects of dehydration temperatures on moisture absorption and dissolution behavior of theophyl-line. Chem Pharm Bull. 2001;49:1526-1530.
12. Otsuka M, Hasegawa H, Matsuda Y. Effect of polymorphic transformation during the extrusion-granulation process on the pharmaceutical properties of carbamazepine granules. Chem Pharm Bull. 1997;45:894-898.
13. Otsuka M, Hasegawa H, Matsuda Y. Effect of polymorphic forms of bulk powders on pharmaceutical properties of carbamazepine granules. Chem Pharm Bull. 1999;47:852-856.
14. Adeyeye CM, Rowley J, Madu D, Javadi M, Sabnis SS. Evaluation of crystallinity and drug release stability of directly compressed theophylline hydrophilic matrix tablets stored under varied moisture conditions. Int J Pharm. 1995;116:65-75.
15. Otsuka M, Kaneniwa N, Kawakami K, Umezawa O. Effects of tableting pressure on hydration kinetics of theophylline anhydrate tablets. J Pharm Pharmacol. 1991;43:226-231.
16. Debnath S, Predecki P, Suryanarayanan R. Use of glancing angle X-ray powder diffractometry to depth profile phase transformations during dissolution of indomethacin and theophylline tablets. Pharm Res. 2004;21:149-159.
17. Collett JH, Rees JA, Dickinson NA. Some parameters describing the dissolution rate of salicylic acid at controlled pH. J Pharm Pharmacol. 1972;24:724-728.
18. Doherty C, York P. Mechanisms of dissolution of frusemide/PVP solid dispersions. Int J Pharm. 1987;34:197-205.
19. Powder Diffraction File 26-1893 (anhydrous theophylline), 27-1977 (theophylline monohydrate) International Centre for Diffraction Data, Newtown Square, Pennsylvania; 1997.
20. Murphy DK, Rodriguez-Cintron F, Langevin B, Kelly RC, Rodriguez-Hornedo N. Solution-mediated phase transformation of anhydrous to dihydrate carbamazepine and the effect of lattice disorder. Int J Pharm. 2002;246:121-134.
21. Sebhatu T, Ahlneck C, Alderborn G. The effect of moisture content on the compression and bond-formation properties of amorphous lactose particles. Int J Pharm. 1997;146:101-114.
22. Suzuki T, Nakagami H. Effect of crystallinity of microcrystalline cellulose on the compactability and dissolution of tablets. Eur J Pharm Biopharm. 1999;47:225-230.
23. Imaizumi H, Nambu N, Nagai T. Stability and several physical properties of amorphous and crystalline forms of indomethacin. Chem Pharm Bull. 1980;28:2565-2569.
24. Nakai Y, Yamamoto K, Terada K, Kajiyama A. Relationships between crystallinity of β-cyclodextrin and tablet characteristics. Chem Pharm Bull. 1985;33:5110-5112.
25. Vromans H, Bolhuis GK, Lerk CF, Kussendrager KD. Studies on tableting properties of lactose. VIII. The effect of variations in primary particle size, percentage of amorphous lactose and addition of a disintegrant on the disintegration of spray-dried lactose tablets. Int J Pharm. 1987;39:201-206.
26. Solvang S, Finholt P. Effect of tablet processing and formulation factors on dissolution rate of the active ingredient in human gastric juice. J Pharm Sci. 1970;59:49-52.
27. Huettenrauch R, Fricke S, Zielke P. Mechanical activation of pharmaceutical systems. Pharm Res. 1985;6:302-306.
28. Sharp JH, Brindley GW, Achar BNN. Numerical data for some commonly used solids-state reaction equations. J Am Ceram Soc. 1963;52:781-791.
29. Ono M, Tozuka Y, Oguchi T, Yamamura S, Yamamoto K. Effects of dehydration temperature on water vapor adsorption and dissolution behavior of carbamazepine. Int J Pharm. 2002;239:1-12.
30. Suihko E, Lehto VP, Ketolainen J, Laine E, Paronen P. Dynamic solid-state and tableting properties of four theophylline forms. Int J Pharm. 2001;217:225-236.